GENE ONLINE|News &
Opinion
Blog

Eye Disease
Partnerships Roche
Roche Offers Up to $1 Billion for Avista to Develop Eye Disease Vectors
2022-07-20
Trials & Approvals Wet Macular Degeneration
Adverum Advances Wet AMD Gene Therapy After Cutting Jobs
2022-07-18
IPO Asia
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Startups Eye Disease
Birmingham University Spinout Looking to Tackle Ocular Surface Disorders
2022-04-26
Deals Eye Development
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
China Eye Disease
Backed by RTW, LENZ Therapeutics Inks $110 Vision Loss Pact with China’s JIXING
2022-04-14
M&A Gene Therapy
Novartis Expands Optogenetics Portfolio By Acquiring Swiss Startup for an Undisclosed Amount
2021-09-21
Licensing Gene Therapy
AbbVie Strikes Gene Therapy Pact with REGENXBIO to Tackle Eye Diseases
2021-09-14
Funding Series C Funding
Oculis Raises $50 Million to Push Ophthalmic Portfolio and Expand International Foothold
2021-05-06
Trials & Approvals Eye Disease
Roche’s Injectable Eye Medicine Lessens Treatment Burden in Two Diseases
2021-02-19
Today In History Anophthalmia
November 12, 1946: English Geneticist Veronica Van Heyningen was Born
2017-11-12
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top